Bookmark list

Subscribe to newsletter

Eden Biodesign and Borean Pharma ApS sign deal to develop novel therapeutic candidate for the treatment of cancer

12-Sep-2007

Bubble-free column packing for pilot scale

Protection for Antibodies and Antigens Coated on Plates

Automated cell counting – fast and efficient

Eden Biodesign Ltd and Borean Pharma ApS announced that they have signed an agreement under which Eden will manufacture MBP-DC-SIGN, a novel therapeutic candidate for the treatment of a range of cancers, for Borean to use in key preclinical studies. The project is expected to complete early in 2008.

MBP-DC-SIGN is one of Borean's products to be based on the Mannose-Binding protein (MBP) platform. The MBP platform is delivering a series of highly potent therapeutics for the treatment of cancers, and is the only scaffold that can induce complement-induced lysis.

The agreement with Borean Pharma is the fourth contract to be announced by Eden Biodesign in the past 7 weeks, following announcements for cGMP manufacturing and development projects with CRUK, University of Birmingham and UMIP.

https://www.bionity.com/en/news/69589/eden-biodesign-and-borean-pharma-aps-sign-deal-to-develop-novel-therapeutic-candidate-for-the-treatment-of-cancer.html

Other news from the department business & finance

Merck Acquires JSR Chromatography Business

Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing

Get the life science industry in your inbox

Eden Biodesign and Borean Pharma ApS sign deal to develop novel therapeutic candidate for the treatment of cancer

Other news from the department business & finance

Merck Acquires JSR Chromatography Business

Novartis agrees to acquire Excellergy, Inc.

Growth in visitor numbers, full halls, clear future topics: analytica 2026 sets standards

Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the Clinic

Berlin names Health Innovation Quarter Berlin-Mitte the new place of the future

US pharmaceutical company Merck is acquiring Terns Pharmaceuticals for around $6.7 billion

Rentschler Biopharma completes the largest expansion in the company’s history in the US

Evonik shortens the path from research to market readinessEvonik launches Innovation Factory

VTU Engineering Germany gets new managing director

German analysis and laboratory industry cautiously optimistic about the current year

Automation and robotics drive growth in the laboratory

Roche launches AI initiative to tackle lengthy development times

Sartorius is counting on a biopharma boom by 2030

Biotech start-up secures €23 million total for cancer and infectious disease platform

German biotech company chooses Saxony-Anhalt for protein production facility

Nine million euros for innovative cancer therapy

Tecan aims to bring unused lab data to life with NVIDIA

Start-up AveThera acquires Fraunhofer site for biologics production

Chemicals still in trouble

​​​3 questions to Susanne Grödl: AI and digital transformation shape analytica 2026

Get the life science industry in your inbox

Most read news

Start-up AveThera acquires Fraunhofer site for biologics production

BioNTech co-founders establish new biotech company

Plastic bottles turned into Parkinson’s medication

More meat, lower risk of dementia: study reveals gene-dependent effect

How old are we really?

Already approved drug is effective against aggressive brain tumors

Roche grows against the trend and invests over 700 million euros in Germany

Disastrous interplay: protein uncovered that makes cancer grow faster

Failed experiment by Cambridge scientists leads to surprise drug development breakthrough

Roche launches AI initiative to tackle lengthy development times

Contraception without hormones: Research alternatives to “the pill”

Vascular killer LDL cholesterol: are butter, eggs and cheese the culprits?

More news from our other portals

AI rebuilds molecules from exploding fragments

German food tech company secures €8 million to combat food waste

Non-destructive battery testing: New method developed

A flexible electrolyte for solid batteries

Amazonian cocoa could become a superfood

Chemical industry at a turning point: six keys to transformation

Why does oat milk sometimes foam perfectly and sometimes not at all?

WACKER cuts over 1,500 jobs to reduce costs by €300 million

How climate-friendly is insect protein really?

How a 270-year-old physics trick could supercharge affordable battery technology

How can startups revolutionize home cooking?

How are 360,000 tons of used batteries per year turned into a treasure trove of raw materials?

Research team achieves breakthrough in breeding winter-hardy faba beans

CO2 to E-Methanol, Aviation Fuels and Speciality Chemicals

BAM, HZB and HU are conducting joint research on sodium batteries

Tailor-made New Battery Materials

Energy storage breakthrough solves the fast-charging problem

Last viewed contents

Dalton Pharma Services and The Henry M. Jackson Foundation Announce a Services Agreement for the Advancement of Military Medicine

YM Biosciences and NRC Biotechnology Research Institute Produce New Breast Cancer Drug Candidates

3 questions to Susanne Grödl: AI and digital transformation shape analytica 2026